General Information
Revision date
2012-04-18
Product name
Cabazitaxel
Chemical name
Cabazitaxel
CAS No.
183133-96-2
1.2.1 Relevant identified uses
To be used only for scientific research and development. Not for use in humans or animals
Emergency telephone
+14166659696 between 0800-1700 (GMT-5
Icons in SDS
Company Information
company name
Toronto Research Chemicals
e-mail address of the competent person responsible for the Safety Data Sheet
orders@trc-canada.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H303, H351, H361
Hazard statements
Code
Statements
H303
May be harmful if swallowed
Section 2
WHMIS Classification
WHMIS Symbols (Canada) D2A Very Toxic Material Causing Other Toxic Effects Reproductive Toxin/Teratogen/Carcinogen 2.1/2.2 Classification of the Substance or Mixture and Label Elements
Classification according to GHS
According to EU Regulation 1272/2008 and US OSHA 1910.1200) Acute Toxicity, Oral (Category 5) Carcinogenicity (Category 2) Reproductive Toxicity (Category 2)
EU Classification
According to EU Regulation 67/548/EEC) May cause cancer. Possible risk of impaired fertility. Possible risk of harm to the unborn child. EU Risk and Safety Statements (According to EU Regulation 67/548/EEC)
Hazard statements
Harmful Xn Risk Codes and Phrases R45 May cause cancer. R62 Possible risk of impaired fertility. R63 Possible risk of harm to the unborn child. Identification (According to EU Regulation 1272/2008 and US OSHA 1910.1200) Toronto Research Chemicals - C046500 Page 1 H303 May be harmful if swallowed. H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child.
Precautionary statements
Codes and Phrases S53 Avoid exposure - obtain special instruction before use. P201 Obtain special instructions before use. P308/P313 IF exposed or concerned: Get medical advice/attention.
Signal word
Warning
2.3 Other hazards
No data available.
